MarketPulse — Real-Time Financial News & Market Analysis

Stryker schedules virtual annual shareholder meeting for May 6, 2026, declares $0.88 quarterly dividend payable April 30, 2026.

$DRVN plunged nearly 40% after disclosing accounting errors and control weaknesses requiring multi-year restatement. Securities fraud lawsuit filed with May 8 deadline.

Daniel Loeb's Third Point buys Constellation Energy while cutting PG&E stake by 32%. Move signals shift toward nuclear-powered AI infrastructure.

U.S. government's $12B critical minerals initiative drives sector realignment. EagleOne Metals gains exposure to uranium, rare earths, copper, and cobalt at C$5M valuation amid projected supply deficits.

Fed Chair Powell holds rates at 3.50%-3.75%, resisting Trump pressure. Markets expect rates to remain unchanged through mid-2027, with Powell poised to maintain stance at his final meeting in May 2026.

AbbVie stock down 11% YTD but trades at 14x forward P/E with 0.49 PEG, suggesting undervaluation amid strong new drug momentum and 3.4% dividend yield.

$PINE and $HD offer distinct dividend strategies for long-term investors: Alpine Income provides 6.34% yield with REIT protections; Home Depot delivers growth plus 2.88% yield.

S&P 500 falls below 6,500, ending 214-day streak above 200-day moving average. Historical patterns suggest 71% recovery probability within 10 days despite geopolitical headwinds.

UAMY shares jump 11.64% following Trump's five-day pause on Iranian strikes. Oil prices plunge 8%, easing inflation concerns and boosting precious metals demand.

Venture Global secured $8.6B financing and signed 1.5 MTPA LNG supply deal with Vitol through 2026, beating Q1 earnings estimates.

$QCOM tumbles 28% from January highs due to weak Q2 guidance and memory chip shortage, but analysts see buying opportunity in edge computing tailwinds.

Shell repurchased 3.2 million shares at 32.79-39.47 EUR across European exchanges via Morgan Stanley, continuing its capital return program to shareholders.

GE Vernova projects 12-24 GW gas power orders in Q1 2026, doubling backlog to $60B by 2028 amid surge in data center and grid modernization demand.

Class action lawsuit filed against $HTGC alleging overstated due diligence and misrepresented portfolio valuations in loan origination and deal sourcing processes.

Philadelphia law firm sues $ROBLOX, $SNAP, Discord alleging platform designs enabled sexual exploitation of minor through inadequate safety measures.

Nvidia rallies 1.44% to $175.18 on Iran tensions relief and announces AI factory partnership with six major energy companies.

Planet Labs PBC surged 388% in 2025 on strong earnings growth and defense demand. The satellite imaging leader guides FY2027 revenue of $427.5M, but valuation concerns loom.

Lululemon stock down nearly 50% amid CEO departure, weak North American sales, and sluggish 2026 growth guidance. International gains offer hope.

Alight Inc. faces securities fraud lawsuit after missing guidance twice, with stock falling 18-38%. Shareholders can claim losses through May 2026.

CRISPR Therapeutics stock declined 9% following a $585.2M convertible notes offering. The gene-editing company boasts FDA-approved Casgevy therapy and $1.8B in reserves but faces steep losses.